Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: A randomised controlled trial

Liam Bourke, Stephen Gilbert, Richard Hooper, Liz A. Steed, Miland Joshi, Jim W. F. Catto, John M. Saxton, Derek J. Rosario

Research output: Contribution to journalArticlepeer-review

156 Citations (Scopus)


Prostate cancer is a key driver of cancer-related global disability-adjusted life-years. Androgen-deprivation therapy (ADT) for advanced disease is linked to fatigue, reduced physical function, and quality of life (QoL).
Original languageEnglish
Pages (from-to)865–872
Number of pages8
JournalEuropean Urology
Issue number5
Early online date4 Oct 2013
Publication statusPublished - May 2014

Cite this